6. QUALITY OF LIFE OF PATIENTS WITH PEPTIC ULCERS: DEVELOPMENT AND VALIDATION OF INSTRUMENT
Main Article Content
Abstract
Introduction: Peptic ulcer disease is a prevalent and frequently recurring ailment, characterized by evolving etiological factors and risk elements that present difficulties in its management. Consequently, the quality of life of those suffering from peptic ulcers might be substantially influenced, thereby raising concerns.
Objective: To develop a Vietnamese version of the Quality-of-Life Instruments for Chronic Diseases - Peptic Ulcer Scale (QLICD-PU), a specialized tool designed to assess the QLICD-PU’ patients.
Materials and methods: In the month of April 2023, a cross-sectional study was undertaken. The data were obtained by conducting direct interviews with patients diagnosed with peptic ulcer disease (PUD) who were undergoing therapy. The interviews were conducted using the QLICD-PU tool.
Results: The study involved a sample size of 146 patients. The examination of the reliability scale resulted in Cronbach’s alpha coefficient that above 0.6. The findings of the Exploratory Factor Analysis (EFA) indicated that all items demonstrated factor loadings of at least 0.3. In the context of Confirmatory Factor Analysis (CFA), the majority of the scale’s components demonstrated satisfactory model fit indices, with the exception of the GFI and NFI indices pertaining to the general Quality of Life (QoL) and PUD-specific sections.
Conclusion: The validity and reliability of the Vietnamese adaptation of the QLICD-PU Quality of Life measure have been demonstrated, rendering it a valuable instrument for evaluating the QLICDPU in Vietnam.
Article Details
Keywords
EFA, quality of life, QLICD-PU, peptic ulcer, reliability.
References
Lancet, 2002, 360(9337): p. 933-941.
[2] Huong HTM et al., Quality of life of patients with
peptic ulcer in General Hospital of Vinh Phuc
province in 2021. Journal of Medical Research,
2022, 156(8): p. 301-310.
[3] Yeomans N et al., Quality of life in chronic
NSAID users: a comparison of the effect of
omeprazole and misoprostol. Scandinavian
Journal of Rheumatology, 2001, 30(6): p.
328-334.
[4] Fujiwara Y et al., Long-term effect of
Helicobacter pylori eradication on quality of
life, body mass index, and newly developed
diseases in Japanese patients with peptic
ulcer disease. Hepato-gastroenterology, 2002,
49(47): p. 1298-1302.
[5] Wan C et al., Development and validation of the
peptic ulcer scale under the system of quality of
life instruments for chronic diseases based on
classical test theory and generalizability theory.
BMC Gastroenterology, 2020. 20(1): p. 422.
[6] Wan C et al., Development and validation of
the general module of the system of quality
of life instruments for chronic diseases and its
comparison with SF-36. Journal of Pain and
Symptom Management, 2011, 42(1): p. 93-104.
[7] Barkun A, G Leontiadis, Systematic Review of
the Symptom Burden, Quality of Life Impairment
and Costs Associated with Peptic Ulcer Disease;
The American Journal of Medicine, 2010,
123(4): p. 358-66.e2.
[8] Artemieva MS et al., Psychosomatic Aspects
and Treatment of Gastrointestinal Pathology;
Psychiatria Danubina, 2021, 33(Suppl 4): p.
1327-1329.